Navigation Links
Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility

PHILADELPHIA (September 2, 2009) The Fox Chase Cancer Center has received an $8 million grant from the National Center for Research Resources of the National Institutes of Health (NCRR/NIH) to expand their laboratory animal research facility. The new facility will support advanced research into the fundamental biological processes underlying cancer, opening the way for the development of new treatments. The funds for the grant were made available through the American Recovery and Reinvestment Act.

According to the Fox Chase administration, construction of the facility, which will house mouse models for cancer research, should begin within a year. The four-story, 25,290 square-foot space will be built alongside and serve as an expansion to the existing animal facility on the Fox Chase campus. The plans entail using the top two floors, roughly 12,910 square feet, for new animal research space, reserving the remaining two floors for support areas and future expansion. The new facility will include high efficiency particulate air (HEPA) ventilation systems and improved support for the state-of-the-art animal care equipment of the sort already being utilized on campus.

"While the current facilities are entirely adequate for the care and feeding of the animal models they house, they are simply not large enough or sophisticated enough to meet the needs of Fox Chase's expanding research faculty," says Harry Rozmiarek, D.V.M., Ph.D., director of the laboratory animal medicine program. "Many of the mice are immunodeficient, and require a special environment with filtered air to keep them from becoming infected by otherwise normal bacterial flora."

Rozmiarek joined Fox Chase in 2004 and initiated a long-range plan at that time to expand and improve the animal research facilities at Fox Chase. "Since then, we have consolidated as much as possible to make more space available for research mice, improved and modernized the animal research facility, and began to systematically convert standard caging and racks to high-density individually ventilated cages." Rozmiarek says. "This expansion is essential to complete the plan and will permit the high quality research at Fox Chase to continue to improve and expand."

"We are grateful that NIH recognizes the need to strengthen basic science infrastructure, and that it has the funding to do so," says Michael V. Seiden, MD, PhD, president and CEO of Fox Chase Cancer Center. "Without such facilities, biomedical research would be impossible and advances in medicine would simply stop moving forward in all fields."


Contact: Greg Lester
Fox Chase Cancer Center

Related medicine news :

1. RainEarth (RNER) Signs Purchase Agreement with HangZhou Municipal No.3 Peoples Hospital
2. Winner Medical Purchased New Purcotton Production Line to Meet Increasing Demand
3. Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common Shares
4. Wasting Millions on Purchases Based on Physician Preference White Paper Now Available From ECRI Institute
5. Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2009 Results and Announces Share Repurchase
6. DaVita Only Dialysis Provider Named on EPAs FORTUNE 500 List of Green Power Purchasers
7. Fox Chase finds that lung cancer patients respond to erlotinib following cetuximab therapy
8. Fox Chase finds all-biologic regimen efficacious and well-tolerated in elderly lung cancer patients
9. Fox Chase researchers identify differences in treatments and outcomes of patients with second primary lung cancers versus those with one primary lung cancer
10. Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program
11. Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent(TM) Portfolio License
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017 OBP ... self-contained, illuminating medical devices, today announced regulatory approval ... Surveillance Agency (or Agência Nacional de Vigilância Sanitária ... single-use, cordless surgical retractor with integrated LED light ... access, illumination and exposure of a tissue pocket ...
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology: